BioLingus (Cayman) Limited (SUBL)
BioLingus (Cayman) Limited will go public soon, but the exact IPO date is still unknown.
IPO Price
$20.00
Shares Offered
360,000
Deal Size
$7.20M

SUBL Balance Sheet

Millions USD. Fiscal year is May - Apr.
Year 20222021
Cash & Equivalents
0.160.11
Short-Term Investments
0.040.13
Cash & Cash Equivalents
0.20.24
Cash Growth
-17.19%-
Other Current Assets
0.070.14
Total Current Assets
0.270.38
Goodwill and Intangibles
0.090.37
Total Long-Term Assets
0.090.37
Total Assets
0.360.74
Accounts Payable
0.50.84
Current Debt
5.022.83
Other Current Liabilities
01
Total Current Liabilities
5.534.67
Long-Term Debt
1.62.45
Other Long-Term Liabilities
0.890
Total Long-Term Liabilities
2.492.45
Total Liabilities
8.027.11
Total Debt
6.635.27
Debt Growth
25.65%-
Retained Earnings
-7.75-6.33
Comprehensive Income
0.09-0.04
Shareholders' Equity
-7.66-6.37
Net Cash / Debt
-6.43-5.03
Working Capital
-5.26-4.29
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).